| API Products | EDMF | CEP | USA DMF | CANADA DMF | WHO | NMPA |
|---|---|---|---|---|---|---|
| Abiraterone Acetate | √ | √ | √ | √ | ||
| Bempedoic acid | √ | √ | ||||
| Betamenthasone Valerate | √ | √ | ||||
| Brivaracetam | √ | √ |
|
|||
| Budesonide | Q2 2023 | Q2 2023 | ||||
| Elagolix | √ | √ | ||||
| Enzalutamide | √ | √ | ||||
| Eplerephone | √ | √ | √ | √ | ||
| Drospirenone | ||||||
| Dydrogesterone | √ | √ | √ | √ | ||
| Fluticasone Propionate | √ | √ | √ | √ | ||
| Fluticasone Furoate | √ | √ | ||||
| Mometasone Furoate | √ | √ | √ | |||
| Pregabalin | √ | √ | √ | √ | ||
| Dolutegravir Sodium | ||||||
|
TDF (Tenofovir Disoproxil Fumarate) |
√ | √ | ||||
|
TAF (Tenofovir Alafenamide Hemifumarate) |
√ | √ | √ | |||
|
TMF (Tenofovir Alafenamide Monofumarate) |
√ | √ |
※ Disclaimer:
Products protected by valid patents in this list are for laboratory analytical/research purposes only and are not offered for sale in countries or area wherethe sale of such products constitutes a patent infringement.Any liability is at buyer's risk.